Pediatric secondary chronic myeloid leukemia following cardiac transplantation for anthracycline-induced cardiomyopathy

Neethu Mohan Menon, Emmanuel Katsanis, Zain Khalpey, Puja Whitlow

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of the hematopoietic stem cell that is exceptionally rare in the first five years of life, particularly as a secondary malignancy. This report describes a case of secondary CML in a four-year-old female occurring after AML treatment. Interestingly, CML developed while on immunosuppression for a heart transplant due to anthracycline-induced cardiomyopathy.

Original languageEnglish (US)
Pages (from-to)166-168
Number of pages3
JournalPediatric Blood and Cancer
Volume62
Issue number1
DOIs
StatePublished - Jan 1 2015

Keywords

  • AML
  • CML
  • Heart transplant
  • Secondary malignancy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Pediatric secondary chronic myeloid leukemia following cardiac transplantation for anthracycline-induced cardiomyopathy'. Together they form a unique fingerprint.

Cite this